Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Great place to work with the opportunity to make a real difference!
Was sind einige der besten Dinge an Ihrem Team?
Strong commitment to help each other succeed.
Was gefällt dir am besten am Führungsteam?
Very transparent and very patient focused
Was macht Sie bei der Arbeit am glücklichsten?
The opportunity to make a difference every day
Was ist das Beste an Ihrem Vergütungspaket?
Great overall package of benefits.
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Fast paced and energetic environment
Other Employee Reviews for Karyopharm Therapeutics
×